IL-17A Is Associated With the Breakdown of the Blood-Brain Barrier in Relapsing-Remitting Multiple Sclerosis

Journal of Neuroimmunology - Netherlands
doi 10.1016/j.jneuroim.2019.04.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Brain and Lesion Volumes Correlate With Edss in Relapsing-Remitting Multiple Sclerosis

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2015English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Symptom Co-Occurrences Associated With Smoking in Individuals With Relapsing-Remitting Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2016English

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1999English

Permeability of the Blood-Brain Barrier Predicts No Evidence of Disease Activity at Two Years After Natalizumab or Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis

Annals of Neurology
Neurology
2018English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy